Urgent Action Needed on Prehospital Tranexamic Acid in Trauma
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Nutbeam T, Roberts I, Weekes L, Shakur-Still H, Brenner A, Ageron F
. Use of tranexamic acid in major trauma: a sex-disaggregated analysis of the Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage (CRASH-2 and CRASH-3) trials and UK trauma registry (Trauma and Audit Research Network) data. Br J Anaesth. 2022; 129(2):191-199.
DOI: 10.1016/j.bja.2022.03.032.
View
2.
Ageron F, Coats T, Darioli V, Roberts I
. Validation of the BATT score for prehospital risk stratification of traumatic haemorrhagic death: usefulness for tranexamic acid treatment criteria. Scand J Trauma Resusc Emerg Med. 2021; 29(1):6.
PMC: 7789642.
DOI: 10.1186/s13049-020-00827-5.
View
3.
Grassin-Delyle S, Shakur-Still H, Picetti R, Frimley L, Jarman H, Davenport R
. Pharmacokinetics of intramuscular tranexamic acid in bleeding trauma patients: a clinical trial. Br J Anaesth. 2020; 126(1):201-209.
DOI: 10.1016/j.bja.2020.07.058.
View
4.
Bivens M, Fritz C, Burke R, Schoenfeld D, Pope J
. State-by-state estimates of avoidable trauma mortality with early and liberal versus delayed or restricted administration of tranexamic acid. BMC Emerg Med. 2022; 22(1):191.
PMC: 9719138.
DOI: 10.1186/s12873-022-00741-2.
View
5.
Girardello C, Carron P, Dami F, Darioli V, Pasquier M, Ageron F
. Evaluation of the prehospital administration of tranexamic acid for injured patients: a state-wide observational study with sex and age-disaggregated analysis. Emerg Med J. 2024; 41(8):452-458.
PMC: 11287560.
DOI: 10.1136/emermed-2023-213806.
View